Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Jan 13, 2015 8:23pm
139 Views
Post# 23316132

RE:RE:i am guessing but i would think by the end of the

RE:RE:i am guessing but i would think by the end of the
LaserStock29 wrote: Interesting concept.. that would be quite a NR...

Upon approval the selling of 100 units to meet 2015 expectations have been met...

I think the better question to ask at this juncture.. is about those ads Theralase posted about the sales manager position and sales reps...

Anyone know whether they got taken down??? what's the status of the recruitment process?

Then one might 'suggest' that units have or have not been 'pre-sold' in terms of 'justifying' another salaried position on TLT's books.

Here's hoping that's true.

65corvettesting wrote: month the TLC2000 would be ready for market. lets hope we have pre sold say 50 to 100 units by then.




I can only make observations based on TLT documents/interviews.

1. I believe they do have new sales reps. I don't recall their staff including this many reps.
https://theralase.com/about-us/careers/
Four territorial sales managers.
One inside sales rep.
One marketing cordinator.

2. I believe they are still hiring additional sales staff.
https://theralase.com/about-us/careers/

Marketing Communications Coordinator

Inside Sales Representative

Director of Marketing

Director of Sales
The successful candidate will have 10+ years of documented experience in leading their team to grow the revenue of medical device companies selling in Canada and the US from < $2 M in sales to more than > $50 M within 5 years. Their proven and well executed sales strategy, coupled with their excellent interpersonal skills, drive to succeed, natural leadership abilities and good old fashioned hard work will create the environment to allow their direct report Territory Sales Managers (“TSMs”), led by their hands-on example, to consistently achieve and / or surpass their quarterly and annual sales objectives.

2. Their latest sedar documents indicate that complete cost of sales are not factored in yet since they are waiting until sales can be converted, thus offset. .. which to me means that they are waiting for TLC2000 launch before full sales arsenal on board.

3. Preorders. They've discussed in the past their emphasis on upgrade paths with customers, even offering discounts and flexible plans.
"Theralase plans to phase out the TLC-1000 system and incentivize its customers to upgrade to the latest technology, the TLC-2000" 
"Theralase is also launching 5 beta prototypes for beta testing by Key Opinion Leaders (KOLs) shortly and then supply pre-commercial prototypes to its Canadian Territory Sales Managers (TSMs) for solicitation of orders and trade-ups of the existing TLC-1000 technology from its existing customer base.
When 4q2015, 1q2015 are out, I'm guessing you'll see very light tlc1000 sales compared to the same periods a year earlier or say 5 years historically... which to me would be customers lined up for TLC2000. It's pretty hard to sell a device even with a good long history when the next generation device to replace it, which has been in development for over 10 years is right around the corner.

4. Roger is hoping to sell 100 units in the first three months per Cory Fleck
"After chatting to Roger White regarding the expected sales of the TLC 2000 he states that they hope to sell around 100 units in the first three months after hitting the market (which is roughly 33 units per month). For conservative sake we will use a lower figure of 15 units to run our numbers. We will also use a profit margin of 70% instead of 75%. Over my time investing, conservative estimates have never lead me astray.

If Theralase can sell 15 units a month at a 70% margin the company would generate $157,500/month.  This number would cover the 150k/month of operating expenses and the continued cancer division research.

As I stated above, the therapeutic division provides a base to the stock price. We should not expect booming sales of the TLC-2000 which would catch investor’s eyes but rather a steady stream of cash entering the company to offset the costs of starting the cancer trails. I continue to believe Theralase is financially strong moving into 2015"

So yeah, it'd be interesting to know if that sales soliciation for upgrades has started and if that has equated into preorders.

Bullboard Posts